Glycyrrhizic acid: A promising carrier material for anticancer therapy
Authors:
- 1 November 2017
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 95, 670-678
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81202480)
- National Natural Science Foundation of China (81302723)
- Natural Science Foundation of Liaoning Province (2015020749)
This publication has 72 references indexed in Scilit:
- Glycyrrhizic Acid Suppresses the Development of Precancerous Lesions via Regulating the Hyperproliferation, Inflammation, Angiogenesis and Apoptosis in the Colon of Wistar RatsPLOS ONE, 2013
- The Anti‐Angiogenic Activities of Glycyrrhizic Acid in Tumor ProgressionPhytotherapy Research, 2012
- Absorption Enhancers: Applications and AdvancesThe AAPS Journal, 2011
- Inhibition of tumor progression by naturally occurring terpenoidsPharmaceutical Biology, 2011
- Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasionJournal of Experimental & Clinical Cancer Research, 2010
- Oncogenic Activation of NF- BCold Spring Harbor Perspectives in Biology, 2010
- Complex of Calcium Receptor Blocker Nifedipine with Glycyrrhizic AcidThe Journal of Physical Chemistry B, 2008
- Transdermal Delivery of Carvedilol Containing Glycyrrhizin and Chitosan as Permeation Enhancers: Biochemical, Biophysical, Microscopic and Pharmacodynamic EvaluationDrug Delivery, 2008
- Complexation of Lappaconitine with Glycyrrhizic Acid: Stability and Reactivity StudiesThe Journal of Physical Chemistry B, 2005
- Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxelCancer Biology & Therapy, 2005